Position in MRK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$69,768,681
+$7,074,141 QoQ
Shares Held
580,004
-2.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $714,031,909 across 12 Drug Manufacturers - General names. MRK ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
221,464 | $203,695,943 | |
| 2 | JNJ |
Johnson & Johnson
|
563,045 | $137,630,719 | |
| 3 | ABBV |
AbbVie Inc.
|
493,002 | $107,223,004 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
580,004 | $69,768,681 | |
| 5 | AMGN |
Amgen Inc
|
143,722 | $50,568,585 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
305,106 | $42,522,623 | |
| 7 | PFE |
Pfizer Inc
|
1,328,456 | $37,303,044 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
493,565 | $29,934,717 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $69,768,681 | 580,004 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $62,694,540 | 595,616 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $52,045,832 | 620,110 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $50,659,629 | 639,965 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $68,896,993 | 767,569 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $77,741,133 | 781,475 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $87,968,459 | 774,643 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $98,207,197 | 793,273 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $80,858,432 | 612,796 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $69,178,313 | 634,547 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $66,628,004 | 647,188 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $76,571,534 | 663,589 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $74,105,422 | 696,545 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $78,139,976 | 704,281 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $61,695,592 | 716,391 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $66,073,998 | 724,734 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $56,406,831 | 687,469 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $42,771,787 | 558,087 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $46,732,690 | 622,190 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $45,654,645 | 587,047 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $46,981,215 | 609,433 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $50,260,596 | 614,433 | Shares | Defined | 2023-03-23 | |
| 2020-09-30 | $53,193,702 | 641,274 | Shares | Defined | 2023-03-23 | |
| 2020-06-30 | $51,049,112 | 660,146 | Shares | Defined | 2023-03-23 | |
| 2020-03-31 | $50,492,623 | 656,260 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||